Relative Bioavailability Study of Emodepside IR-tablets and Solution
Condition: Filariasis Intervention: Drug: Emodepside (BAY 44-4400) Sponsors: Drugs for Neglected Diseases; Bayer; Bill and Melinda Gates Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2017 Category: Research Source Type: clinical trials
Safety, Tolerability and PK of Multiple-ascending Doses of Emodepside
Condition: Filariasis Intervention: Drug: LSF emodepside (BAY 44-4400) oral solution (1mg/mL) Sponsors: Drugs for Neglected Diseases; Bayer; Bill and Melinda Gates Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2017 Category: Research Source Type: clinical trials
Relative Bioavailability Study of Emodepside IR-tablets and Solution
Condition: Filariasis Intervention: Drug: Emodepside (BAY 44-4400) Sponsors: Drugs for Neglected Diseases; Bayer; Bill and Melinda Gates Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2017 Category: Research Source Type: clinical trials
Safety, Tolerability and PK of Multiple-ascending Doses of Emodepside
Condition: Filariasis Intervention: Drug: LSF emodepside (BAY 44-4400) oral solution (1mg/mL) Sponsors: Drugs for Neglected Diseases; Bayer; Bill and Melinda Gates Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 25, 2017 Category: Research Source Type: clinical trials
Prevalence Studies After Triple Drug Therapy for Lymphatic Filariasis
Condition: Lymphatic Filariases Interventions: Drug: 2 drug dose - DA; Drug: 3 drug dose - IDA Sponsors: Washington University School of Medicine; Case Western Reserve University; Ministere de la Sante Publique et de la Population, Haiti; Indonesia University; Papua New Guinea Institute for Medical Research Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2017 Category: Research Source Type: clinical trials